Flavin and Hallucinations - a phase IV clinical study of FDA data

Summary:

Hallucinations is reported as a side effect among people who take Flavin (riboflavin (vitamin b2)), especially for people who are female, 60+ old, also take Xyrem, and have Cataplexy.

The phase IV clinical study analyzes which people have Hallucinations when taking Flavin. It is created by eHealthMe based on reports of 2,778 people who have side effects when taking Flavin from the FDA, and is updated regularly.

What is Flavin?

Flavin has active ingredients of riboflavin (vitamin b2). eHealthMe is studying from 2,870 Flavin users. Check the latest studies of Flavin.

What is Hallucinations?

Hallucinations (sensations that appear real but are created by your mind) is found to be associated with 1,890 drugs and 2,728 conditions by eHealthMe. Check the latest studies of Hallucinations.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

2,778 people reported to have side effects when taking Flavin.
Among them, 17 people (0.61%) have Hallucinations.

Among these 17 people:

What is the gender of people who have Hallucinations when taking Flavin? *

female: 68.75 %
male: 31.25 %

What is the age of people who have Hallucinations when taking Flavin? *

What are other drugs people take besides Flavin? *

What are other side effects people have besides Hallucinations? *

Fall: 6 people, 35.29%
Confusional State: 6 people, 35.29%
Insomnia (sleeplessness): 6 people, 35.29%
Dehydration (dryness resulting from the removal of water): 5 people, 29.41%
Headache (pain in head): 4 people, 23.53%
Fainting (loss of consciousness and postural tone): 4 people, 23.53%
Nausea (feeling of having an urge to vomit): 4 people, 23.53%
Muscle Spasms (muscle contraction): 3 people, 17.65%
Osteoporosis (bones weak and more likely to break): 3 people, 17.65%
Oropharyngeal Pain: 3 people, 17.65%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 35.29%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 35.29%
Drowsiness: 4 people, 23.53%
Pain: 3 people, 17.65%
Delusion (a false belief or opinion): 3 people, 17.65%
Abdominal Rigidity: 3 people, 17.65%
Parkinson's Disease: 2 people, 11.76%
Migraine (headache): 2 people, 11.76%
Melas Syndrome (melas (myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) is a progressive neurodegenerative disorder): 1 person, 5.88%
Lymphoma (cancer that begins in immune system cells): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Flavin and have Hallucinations?

- Check whether Hallucinations is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Flavin:

Flavin (2,870 reports)

Hallucinations treatments and more:

Hallucinations (98,683 reports)

Browse all side effects of Flavin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hallucinations:

Hallucinations (1,890 drugs)

Browse all the conditions that are associated with Hallucinations:

Hallucinations (2,728 conditions)

Related publications that referenced our studies

Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .
Boschee T, DO PGY II, "Acute Hallucinations: Where Did That Come From?", , 2007 Jan .
Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .
Boschee T, DO PGY II, "Acute Hallucinations: Where Did That Come From?", , 2007 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on riboflavin (vitamin b2) (the active ingredients of Flavin) and Flavin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.